Web Desk
The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to fast track clinical trials of the indigenous COVID-19 vaccine. ICMR’s National Institute of Virology (NIV) in Pune has provided the virus strain to BBIL to develop the vaccine.
The clinical trials will be held in 12 institutes across the country. In a letter to these institutes, the ICMR stated that it aims to launch the vaccine for public health use by August 15, after completion of all clinical trials.
Meanwhile, India’s second COVID-19 vaccine produced pharma giant Zydus Cadila got approval from the Drug Controller General of India (DCGI) to conduct phase I and phase II human clinical trials.
Kochi: A business seminar aimed at providing exporters and the business community with insights into…
The International Chamber for Indian Music & Culture, an international initiatives of Parakkadathu Koyickal Trust,…
India Union Budget was sector diversified and considering the increasing global economic challenges, the India…
MUSCAT: The ‘Who’s Who of Oman Indian s’, which will include detailed information on prominent…
By Joseph Maliakan The Muslims and the nomads in the Himalayan state of Uttarkhand which…
By Joseph Maliakan The Supreme Court on 29 December 2025 in an unprecedented but welcome…
This website uses cookies.